| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |